Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vertex, Bristol-Myers enter agreement for Phase 2 studies of VX-135, daclatasvir
Vertex, Bristol-Myers enter agreement for Phase 2 studies of VX-135, daclatasvir
Vertex, Bristol-Myers enter agreement for Phase 2 studies of VX-135, daclatasvir
Submitted by
admin
on April 5, 2013 - 10:25am
Source:
Yahoo/Fly on the Wall
News Tags:
VX-135
Vertex Pharmaceuticals
Bristol-Myers Squibb
daclatasvir
hepatitis C
Headline:
Vertex, Bristol-Myers enter agreement for Phase 2 studies of VX-135, daclatasvir
Do Not Allow Advertisers to Use My Personal information
